Where Art Thou O treatment for diabetic neuropathy: the sequel

References

• Malik RA. Wherefore Art Thou, O treatment for diabetic neuropathy? Int Rev Neurobiol. 2016;127:287–317.
   PubMed Web of Science ®Google Scholar
• Walsh JW, Hoffstad OJ, Sullivan MO, et al. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33(11):1493–1498. doi: 10.1111/dme.13054
   PubMed Web of Science ®Google Scholar
• Rodriguez-Acuña R, Mayoral E, Aguilar-Diosdado M, et al. Andalusian program for early detection of diabetic retinopathy: implementation and 15-year follow-up of a population-based screening program in Andalusia, Southern Spain. BMJ Open Diabetes Res Care. 2020;8(1):e001622. doi: 10.1136/bmjdrc-2020-001622
   PubMed Web of Science ®Google Scholar
• Wang LZ, Cheung CY, Tapp RJ, et al. Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. Br J Ophthalmol. 2017;101(10):1352–1360. doi: 10.1136/bjophthalmol-2016-310002
   PubMed Web of Science ®Google Scholar
• Zhang G, Lin JW, Wang J, et al. Automated multidimensional deep learning platform for referable diabetic retinopathy detection: a multicentre, retrospective study. BMJ Open. 2022;12(7):e060155. doi: 10.1136/bmjopen-2021-060155
   PubMed Web of Science ®Google Scholar
• Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open. 2014;4(2):e004015. doi: 10.1136/bmjopen-2013-004015
   PubMed Web of Science ®Google Scholar
• Jacoba CMP, Doan D, Salongcay RP, et al. Performance of automated machine learning for diabetic retinopathy Image classification from multi-field handheld retinal images. Ophthalmol Retina. 2023;7(8):703–712. doi: 10.1016/j.oret.2023.03.003
   PubMedGoogle Scholar
• D’Souza RS, Barman R, Joseph A, et al. Evidence-based treatment of painful diabetic neuropathy: a systematic review. Curr Pain Headache Rep. 2022;26(8):583–594. doi: 10.1007/s11916-022-01061-7
   PubMed Web of Science ®Google Scholar
• Abd-Elsayed AA, Marcondes LP, Loris ZB, et al. Painful diabetic peripheral neuropathy - a survey of patient experiences. J Pain Res. 2023;16:2269–2285. doi: 10.2147/JPR.S409876
   PubMed Web of Science ®Google Scholar
• Cazzato D, Lauria G. Small fibre neuropathy. Curr Opin Neurol. 2017;30(5):490–499. doi: 10.1097/WCO.0000000000000472
   PubMed Web of Science ®Google Scholar
• Cox ER, Gajanand T, Burton NW, et al. Effect of different exercise training intensities on musculoskeletal and neuropathic pain in inactive individuals with type 2 diabetes - preliminary randomised controlled trial. Diabet Res Clin Pract. 2020;164:108168. doi: 10.1016/j.diabres.2020.108168
   PubMed Web of Science ®Google Scholar
• Egenolf N, Zu Altenschildesche CM, Kreß L, et al. Diagnosing small fiber neuropathy in clinical practice: a deep phenotyping study. Ther Adv Neurol Disord. 2021;14:17562864211004318.
   Web of Science ®Google Scholar
• Dyck PJB, González-Duarte A, Obici L, et al. Development of measures of polyneuropathy impairment in hATTR amyloidosis: from NIS to mNIS + 7. J Neurol Sci. 2019;405:116424. doi: 10.1016/j.jns.2019.116424
   PubMed Web of Science ®Google Scholar
• Al-Bazz DY, Nelson AJ, Burgess J, et al. Is nerve electrophysiology a Robust primary endpoint in clinical trials of treatments for diabetic peripheral neuropathy? Diagnostics. 2022;12(3):12. doi: 10.3390/diagnostics12030731
   Web of Science ®Google Scholar
• Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF clinical Investigator group. JAMA. 2000;284(17):2215–2221. doi: 10.1001/jama.284.17.2215
   PubMed Web of Science ®Google Scholar
• Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34(9):2054–2060. doi: 10.2337/dc11-0503
   PubMed Web of Science ®Google Scholar
• Balasubramanian GV, Chockalingam N, Naemi R. The role of cutaneous microcirculatory responses in tissue injury, inflammation and repair at the foot in diabetes. Front Bioeng Biotechnol. 2021;9:732753. doi: 10.3389/fbioe.2021.732753
   PubMed Web of Science ®Google Scholar
• Fouchard M, Misery L, Le Garrec R, et al. Alteration of pressure-induced vasodilation in aging and diabetes, a Neuro-Vascular damage. Front Physiol. 2019;10:862.
   PubMed Web of Science ®Google Scholar
• Armstrong DG, Boulton AJM, Bus SA, et al. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375. doi: 10.1056/NEJMra1615439
   PubMed Web of Science ®Google Scholar
• Devigili G, Cazzato D, Lauria G. Clinical diagnosis and management of small fiber neuropathy: an update on best practice. Expert Rev Neurother. 2020;20(9):967–980. doi: 10.1080/14737175.2020.1794825
   PubMed Web of Science ®Google Scholar
• Worthington A, Kalteniece A, Ferdousi M, et al. Spinal Inhibitory dysfunction in patients with painful or Painless diabetic neuropathy. Diabetes Care. 2021;44(8):1835–1841. doi: 10.2337/dc20-2797
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Argyros B, Russell JW, et al. 3rd Multicenter trial of the proficiency of smart quantitative sensation tests. Muscle Nerve. 2014;49(5):645–653. doi: 10.1002/mus.23982
   PubMed Web of Science ®Google Scholar
• Kessler JA, Smith AG, Cha BS, et al. Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy. Ann Clin Transl Neurol. 2015;2(5):465–478. doi: 10.1002/acn3.186
   PubMed Web of Science ®Google Scholar
• Kessler JA, Shaibani A, Sang CN, et al. Gene therapy for diabetic peripheral neuropathy: a randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin Transl Sci. 2021;14(3):1176–1184. doi: 10.1111/cts.12977
   PubMed Web of Science ®Google Scholar
• Wahren J, Foyt H, Daniels M, et al. Long-acting c-peptide and neuropathy in type 1 diabetes: A 12-month clinical trial. Diabetes Care. 2016;39(4):596–602. doi: 10.2337/dc15-2068
   PubMed Web of Science ®Google Scholar
• Fonseca VA, Lavery LA, Thethi TK, et al. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am j med. 2013;126(2):141–149. doi: 10.1016/j.amjmed.2012.06.022
   PubMed Web of Science ®Google Scholar
• Lauria G, Faber CG, Cornblath DR. Skin biopsy and small fibre neuropathies: facts and thoughts 30 years later. J Neurol Neurosurg Psychiatry. 2022;93(9):915–918. doi: 10.1136/jnnp-2021-327742
   PubMed Web of Science ®Google Scholar
• Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019;142(12):3728–3736. doi: 10.1093/brain/awz333
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Rajan S, Senechal K, et al. A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies. Muscle Nerve. 2023;67(5):363–370. doi: 10.1002/mus.27745
   PubMed Web of Science ®Google Scholar
• Khan KS, Overgaard K, Tankisi H, et al. Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial. Diabetologia. 2022;65(4):620–631. doi: 10.1007/s00125-021-05646-6
   PubMed Web of Science ®Google Scholar
• Perkins BA, Lovblom LE, Bril V, et al. Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study. Diabetologia. 2018;61(8):1856–1861. doi: 10.1007/s00125-018-4653-8
   PubMed Web of Science ®Google Scholar
• Gad H, Petropoulos IN, Khan A, et al. Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: a systematic review and meta-analysis. J Diabetes Investig. 2022;13(1):134–147. doi: 10.1111/jdi.13643
   PubMed Web of Science ®Google Scholar
• Dabbah MA, Graham J, Petropoulos I, et al. Dual-model automatic detection of nerve-fibres in corneal confocal microscopy images. Med Image Comput Comput Assist Interv. 2010;13:300–307.
   PubMedGoogle Scholar
• Dabbah MA, Graham J, Petropoulos IN, et al. Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging. Med Image Anal. 2011;15(5):738–747. doi: 10.1016/j.media.2011.05.016
   PubMed Web of Science ®Google Scholar
• Williams BM, Borroni D, Liu R, et al. An artificial intelligence-based deep learning algorithm for the diagnosis of diabetic neuropathy using corneal confocal microscopy: a development and validation study. Diabetologia. 2020;63(2):419–430. doi: 10.1007/s00125-019-05023-4
   PubMed Web of Science ®Google Scholar
• Salahouddin T, Petropoulos IN, Ferdousi M, et al. Artificial intelligence–based classification of diabetic peripheral neuropathy from corneal confocal microscopy images. Diabetes Care. 2021;44(7):e151–e153. doi: 10.2337/dc20-2012
   PubMed Web of Science ®Google Scholar
• Chen X, Graham J, Dabbah MA, et al. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care. 2015;38(6):1138–1144. doi: 10.2337/dc14-2422
   PubMed Web of Science ®Google Scholar
• Alam U, Jeziorska M, Petropoulos IN, et al. Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. PLoS One. 2017;12(7):e0180175. doi: 10.1371/journal.pone.0180175
   PubMed Web of Science ®Google Scholar
• Moulton EA, Borsook D. C-Fiber Assays in the Cornea vs. Skin. Brain Sci. 2019;9(11):320. doi: 10.3390/brainsci9110320
   PubMed Web of Science ®Google Scholar
• Pritchard N, Edwards K, Russell AW, et al. Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes. Diabetes Care. 2015;38(4):671–675. doi: 10.2337/dc14-2114
   PubMed Web of Science ®Google Scholar
• Lovblom LE, Halpern EM, Wu T, et al. In vivo corneal confocal microscopy and Prediction of Future-incident neuropathy in type 1 diabetes: a preliminary longitudinal analysis. Can J Diabetes. 2015;39(5):390–397. doi: 10.1016/j.jcjd.2015.02.006
   PubMed Web of Science ®Google Scholar
• Edwards K, Pritchard N, Dehghani C, et al. Corneal confocal microscopy best identifies the development and progression of neuropathy in patients with type 1 diabetes. J Diabetes Complications. 2017;31(8):1325–1327. doi: 10.1016/j.jdiacomp.2017.04.025
   PubMed Web of Science ®Google Scholar
• Kalteniece A, Ferdousi M, Petropoulos I, et al. Greater corneal nerve loss at the inferior whorl is related to the presence of diabetic neuropathy and painful diabetic neuropathy. Sci Rep. 2018;8(1):3283. doi: 10.1038/s41598-018-21643-z
   PubMed Web of Science ®Google Scholar
• Ferdousi M, Azmi S, Kalteniece A, et al. Greater small nerve fibre damage in the skin and cornea of type 1 diabetic patients with painful compared to painless diabetic neuropathy. Eur J Neurol. 2021;28(5):1745–1751. doi: 10.1111/ene.14757
   PubMed Web of Science ®Google Scholar
• Püttgen S, Bönhof GJ, Strom A, et al. Augmented corneal nerve fiber branching in painful compared with painless diabetic neuropathy. J Clin Endocrinol Metab. 2019;104(12):6220–6228. doi: 10.1210/jc.2019-01072
   PubMed Web of Science ®Google Scholar
• Carmichael J, Fadavi H, Ishibashi F, et al. Implementation of corneal confocal microscopy for screening and early detection of diabetic neuropathy in primary care alongside retinopathy screening: Results from a feasibility study. Front Endocrinol. 2022;13:891575. doi:10.3389/fendo.2022.891575
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Evans GW, Gerstein HC, et al. Prineas R and action to control cardiovascular risk in diabetes study G. Effects of cardiac autonomic dysfunction on mortality risk in the Action to control Cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33(7):1578–1584. doi: 10.2337/dc10-0125
   PubMed Web of Science ®Google Scholar
• Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. doi: 10.1038/s41572-019-0092-1
   PubMed Web of Science ®Google Scholar
• Malik RA. Why are there no good treatments for diabetic neuropathy? Lancet Diabetes Endocrinol. 2014;2(8):607–609. doi: 10.1016/S2213-8587(14)70067-1
   PubMed Web of Science ®Google Scholar
• Javed S, Alam U, Malik RA. Treating diabetic neuropathy: present strategies and emerging solutions. Rev Diabet Stud. 2015;12(1–2):63–83. doi: 10.1900/RDS.2015.12.63
   PubMedGoogle Scholar
• Culver DA, Dahan A, Bajorunas D, et al. Cibinetide improves corneal nerve fiber Abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain. Invest Ophthalmol Vis Sci. 2017;58(6):Bio52–bio60. doi: 10.1167/iovs.16-21291
   PubMed Web of Science ®Google Scholar
• Dahan A, Dunne A, Swartjes M, et al. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. In: Mol Med. Vol. 19. p. 334–345. Cambridge, Mass; 2013. doi: 10.2119/molmed.2013.00122
   Google Scholar
• Brines M, Dunne AN, van Velzen M, et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol Med. 2015;20(1):658–666. doi: 10.2119/molmed.2014.00215
   PubMedGoogle Scholar
• Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–551. doi: 10.1016/S0140-6736(17)33102-1
   PubMed Web of Science ®Google Scholar
• Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29(6):1294–1299. doi: 10.2337/dc06-0224
   PubMed Web of Science ®Google Scholar
• Kender Z, von Rauchhaupt E, Schwarz D, et al. Six-month periodic fasting does not affect somatosensory nerve function in type 2 diabetes patients. Front Endocrinol. 2023;14:1143799. doi: 10.3389/fendo.2023.1143799
   PubMed Web of Science ®Google Scholar
• Aghili R, Malek M, Tanha K, et al. The effect of bariatric surgery on peripheral polyneuropathy: a systematic review and meta-analysis. Obes Surg. 2019;29(9):3010–3020. doi: 10.1007/s11695-019-04004-1
   PubMed Web of Science ®Google Scholar
• Reynolds EL, Watanabe M, Banerjee M, et al. The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity. Diabetologia. 2023;66(7):1–16. doi: 10.1007/s00125-023-05899-3
   PubMed Web of Science ®Google Scholar
• Adam S, Azmi S, Ho JH, et al. Improvements in diabetic neuropathy and Nephropathy after bariatric surgery: a prospective cohort study. Obes Surg. 2021;31(2):554–563. doi: 10.1007/s11695-020-05052-8
   PubMed Web of Science ®Google Scholar
• Azmi S, Ferdousi M, Liu Y, et al. Bariatric surgery leads to an improvement in small nerve fibre damage in subjects with obesity. Int J Obes (Lond). 2021;45(3):631–638. doi: 10.1038/s41366-020-00727-9
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Little AA, Feldman EL, et al. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;6:CD007543–CD007543. doi: 10.1002/14651858.CD007543.pub2
   PubMed Web of Science ®Google Scholar
• Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care. 2007;30(10):2608–2612. doi: 10.2337/dc07-0870
   PubMed Web of Science ®Google Scholar
• Tavakoli M, Mitu-Pretorian M, Petropoulos IN, et al. Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes. 2013;62(1):254–260. doi: 10.2337/db12-0574
   PubMed Web of Science ®Google Scholar
• Azmi S, Jeziorska M, Ferdousi M, et al. Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation. Diabetologia. 2019;62(8):1478–1487. doi: 10.1007/s00125-019-4897-y
   PubMed Web of Science ®Google Scholar
• Ponirakis G, Abdul-Ghani MA, Jayyousi A, et al. Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar study. BMJ Open Diabetes Res Care. 2020;8(1):e001420. doi: 10.1136/bmjdrc-2020-001420
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–350. doi: 10.1056/NEJMoa032782
   PubMed Web of Science ®Google Scholar
• Wiggin TD, Sullivan KA, Pop-Busui R, et al. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58(7):1634–1640. doi: 10.2337/db08-1771
   PubMed Web of Science ®Google Scholar
• Davis TM, Yeap BB, Davis WA, et al. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle diabetes study. Diabetologia. 2008;51(4):562–566. doi: 10.1007/s00125-007-0919-2
   PubMed Web of Science ®Google Scholar
• Rajamani K, Colman PG, Li LP, et al. Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. Lancet. 2009;373(9677):1780–1788. doi: 10.1016/S0140-6736(09)60698-X
   PubMed Web of Science ®Google Scholar
• Teo CHY, Lin MT, Lee IXY, Koh SK, Zhou L, Goh DS, Choi H, Koh HWL, Lam AYR, Lim PS, Mehta JS, Kovalik JP, Coffman TM, Tan HC and Liu YC. Oral peroxisome proliferator–activated Receptor-α agonist enhances corneal nerve regeneration in patients with type 2 diabetes. Diabetes. 2023;72(7):932–946. doi: 10.2337/db22-0611
   PubMed Web of Science ®Google Scholar
• Lewis EJH, Perkins BA, Lovblom LE, et al. Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trial. Neurology. 2017;88(24):2294–2301. doi: 10.1212/WNL.0000000000004033
   PubMed Web of Science ®Google Scholar
• Britten-Jones AC, Kamel JT, Roberts LJ, et al. Investigating the neuroprotective effect of Oral Omega-3 fatty acid supplementation in type 1 diabetes (nPROOFS1): a randomized placebo-controlled trial. Diabetes. 2021;70(8):1794–1806. doi: 10.2337/db21-0136
   PubMed Web of Science ®Google Scholar
• Ponirakis G, Petropoulos IN, Alam U, et al. Hypertension Contributes to neuropathy in patients with type 1 diabetes. Am J Hypertens. 2019;32(8):796–803. doi: 10.1093/ajh/hpz058
   PubMed Web of Science ®Google Scholar
• Reja A, Tesfaye S, Harris ND, et al. Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabetic Med. 1995;12(4):307–309. doi: 10.1111/j.1464-5491.1995.tb00482.x
   PubMed Web of Science ®Google Scholar
• Malik RA, Williamson S, Abbott C, et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet. 1998;352(9145):1978–1981. doi: 10.1016/S0140-6736(98)02478-7
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Lauria G, Iliev IP, et al. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension. 2011;58(5):776–783. doi: 10.1161/HYPERTENSIONAHA.111.174474
   PubMed Web of Science ®Google Scholar
• Didangelos T, Tziomalos K, Margaritidis C, et al. Efficacy of Administration of an angiotensin converting enzyme inhibitor for two years on autonomic and peripheral neuropathy in patients with diabetes mellitus. J Diabetes Res. 2017;2017:6719239. doi: 10.1155/2017/6719239
   PubMed Web of Science ®Google Scholar
• Gæde P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–393. doi: 10.1056/NEJMoa021778
   PubMed Web of Science ®Google Scholar
• Gaede P, Oellgaard J, Carstensen B, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59(11):2298–2307. doi: 10.1007/s00125-016-4065-6
   PubMed Web of Science ®Google Scholar